[ Price : $8.95]
FDA approves the first at-home, prescription-only brain-stimulation device to treat major depressive disorder.[ Price : $8.95]
Rep. Jan Schakowsky and Sen. Dick Durbin reintroduce their Medical Device Recall Improvement Act to improve medical device recall ...[ Price : $8.95]
Serina Therapeutics files a complete response to an FDA clinical hold on SER-252, the companys lead investigational therapy for ad...[ Price : $8.95]
FDA weighs changes to a long-standing labeling rule for dietary supplements and will temporarily exercise enforcement discretion o...[ Price : $8.95]
FDA warns Brookhaven, GA-based Ponya Therapeutics about violations of regulations governing human cells, tissues, and cellular and...[ Price : $8.95]
FDA clears a Lumos Labs 510(k) for LumosityRx, a prescription digital therapeutic intended to improve attention in adults with att...[ Price : $8.95]
Roche reports positive Phase 3 lidERA trial results for its giredestrant selective estrogen receptor degrader endocrine therapy in...[ Price : $8.95]
Reuters reports that Daniel McMullen, the former director of the CDRH Office of Neurological and Physical Medicine Devices, has jo...